MicroRNAs in diabetic cardiomyopathy and clinical perspectives.
作者信息
Zhou Qiulian, Lv Dongchao, Chen Ping, Xu Tianzhao, Fu Siyi, Li Jin, Bei Yihua
机构信息
Regeneration Lab and Experimental Center of Life Sciences, School of Life Science, Shanghai University Shanghai, China ; Shanghai Key Laboratory of Bio-Energy Crops, School of Life Science, Shanghai University Shanghai, China.
Regeneration Lab and Experimental Center of Life Sciences, School of Life Science, Shanghai University Shanghai, China ; Shanghai Key Laboratory of Bio-Energy Crops, School of Life Science, Shanghai University Shanghai, China ; Innovative Drug Research Center of Shanghai University Shanghai, China.
出版信息
Front Genet. 2014 Jun 25;5:185. doi: 10.3389/fgene.2014.00185. eCollection 2014.
Abstract
摘要
相似文献
1
MicroRNAs in diabetic cardiomyopathy and clinical perspectives.糖尿病性心肌病中的微小RNA及临床前景
Front Genet. 2014 Jun 25;5:185. doi: 10.3389/fgene.2014.00185. eCollection 2014.
2
Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.微小 RNA 在糖尿病性心肌病中的作用：从机制到干预。
Biochim Biophys Acta Mol Basis Dis. 2017 Aug;1863(8):2070-2077. doi: 10.1016/j.bbadis.2017.03.013. Epub 2017 Mar 24.
3
Autophagy in the diabetic heart: A potential pharmacotherapeutic target in diabetic cardiomyopathy.糖尿病心脏中的自噬：糖尿病心肌病的潜在药物治疗靶点。
Ageing Res Rev. 2021 Jul;68:101338. doi: 10.1016/j.arr.2021.101338. Epub 2021 Apr 7.
4
Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and Perspectives.微小RNA对糖尿病心肌病的亚临床检测：挑战与展望
J Diabetes Res. 2016;2016:6143129. doi: 10.1155/2016/6143129. Epub 2015 Dec 6.
5
Emerging role of epigenetics and miRNA in diabetic cardiomyopathy.表观遗传学和 miRNA 在糖尿病心肌病中的新兴作用。
Cardiovasc Pathol. 2013 Mar-Apr;22(2):117-25. doi: 10.1016/j.carpath.2012.07.004. Epub 2012 Aug 28.
6
Diabetic Cardiomiopathy Progression is Triggered by miR122-5p and Involves Extracellular Matrix: A 5-Year Prospective Study.糖尿病心肌病的进展是由 miR122-5p 触发的，并涉及细胞外基质：一项为期 5 年的前瞻性研究。
JACC Cardiovasc Imaging. 2021 Jun;14(6):1130-1142. doi: 10.1016/j.jcmg.2020.10.009. Epub 2020 Nov 18.
7
LncRNAs and miRs as epigenetic signatures in diabetic cardiac fibrosis: new advances and perspectives.长链非编码 RNA 和微小 RNA 作为糖尿病心脏纤维化的表观遗传特征：新的进展和展望。
Endocrine. 2018 Nov;62(2):281-291. doi: 10.1007/s12020-018-1688-z. Epub 2018 Jul 27.
8
MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy.微小RNA-30d通过直接靶向糖尿病心肌病中的叉头框蛋白O3a调控心肌细胞焦亡。
Cell Death Dis. 2014 Oct 23;5(10):e1479. doi: 10.1038/cddis.2014.430.
9
Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice.链脲佐菌素诱导的糖尿病小鼠心脏中差异表达的 microRNAs 及其靶基因。
Mol Med Rep. 2011 Jul-Aug;4(4):633-40. doi: 10.3892/mmr.2011.489. Epub 2011 May 16.
10
Role of Non-coding RNA in Diabetic Cardiomyopathy.非编码 RNA 在糖尿病心肌病中的作用。
Adv Exp Med Biol. 2020;1229:181-195. doi: 10.1007/978-981-15-1671-9_10.
引用本文的文献
1
From Type 2 Diabetes Mellitus To Diabetic Cardiomyopathy - A Systematic Review On The Role Of MicroRNA.从2型糖尿病到糖尿病性心肌病——关于微小RNA作用的系统综述
Curr Diab Rep. 2025 Jul 15;25(1):42. doi: 10.1007/s11892-025-01590-6.
2
Advances in diabetic cardiomyopathy: current and potential management strategies and emerging biomarkers.糖尿病性心肌病的进展：当前及潜在的管理策略与新兴生物标志物
Ann Med Surg (Lond). 2025 Jan 9;87(1):224-233. doi: 10.1097/MS9.0000000000002857. eCollection 2025 Jan.
3
Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy-Challenges and Prospectives.糖尿病性心肌病药物治疗的批判性评价——挑战与展望
Pharmaceuticals (Basel). 2025 Jan 20;18(1):134. doi: 10.3390/ph18010134.
4
Swimming alleviates myocardial fibrosis of type II diabetic rats through activating miR-34a-mediated SIRT1/PGC-1α/FNDC5 signal pathway.游泳通过激活 miR-34a 介导的 SIRT1/PGC-1α/FNDC5 信号通路缓解 II 型糖尿病大鼠的心肌纤维化。
PLoS One. 2024 Sep 9;19(9):e0310136. doi: 10.1371/journal.pone.0310136. eCollection 2024.
5
Regulation of HIF-1 by MicroRNAs in Various Cardiovascular Diseases.miRNAs 对各种心血管疾病中 HIF-1 的调控作用
Curr Cardiol Rev. 2023;19(5):51-56. doi: 10.2174/1573403X19666230330105259.
6
Positive feedback loop of miR-320 and CD36 regulates the hyperglycemic memory-induced diabetic diastolic cardiac dysfunction.miR-320与CD36的正反馈回路调节高血糖记忆诱导的糖尿病性舒张性心脏功能障碍。
Mol Ther Nucleic Acids. 2022 Dec 14;31:122-138. doi: 10.1016/j.omtn.2022.12.009. eCollection 2023 Mar 14.
7
Role of novel biomarkers in diabetic cardiomyopathy.新型生物标志物在糖尿病性心肌病中的作用。
World J Diabetes. 2021 Jun 15;12(6):685-705. doi: 10.4239/wjd.v12.i6.685.
8
Long non-coding RNA KCNQ1OT1 increases the expression of PDCD4 by targeting miR-181a-5p, contributing to cardiomyocyte apoptosis in diabetic cardiomyopathy.长链非编码 RNA KCNQ1OT1 通过靶向 miR-181a-5p 增加 PDCD4 的表达，导致糖尿病心肌病中心肌细胞凋亡。
Acta Diabetol. 2021 Sep;58(9):1251-1267. doi: 10.1007/s00592-021-01713-x. Epub 2021 Apr 27.
9
MiR-144 affects proliferation and apoptosis of high glucose-induced AC16 cardiomyocytes by regulating CTRP3/JNK signaling.微小RNA-144通过调控C1q/TNF相关蛋白3/应激活化蛋白激酶信号通路影响高糖诱导的AC16心肌细胞的增殖和凋亡。
Int J Clin Exp Pathol. 2020 Feb 1;13(2):142-152. eCollection 2020.
10
Exercise as A Potential Therapeutic Target for Diabetic Cardiomyopathy: Insight into the Underlying Mechanisms.运动作为糖尿病性心肌病的潜在治疗靶点：潜在机制的探索。
Int J Mol Sci. 2019 Dec 12;20(24):6284. doi: 10.3390/ijms20246284.
本文引用的文献
1
MicroRNAs: the underlying mediators of pathogenetic processes in vascular complications of diabetes.MicroRNAs：糖尿病血管并发症发病机制过程中的潜在介导物。
Can J Diabetes. 2013 Oct;37(5):339-44. doi: 10.1016/j.jcjd.2013.07.003.
2
Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.糖尿病心肌病：抗氧化信号通路为靶点的发病机制和新治疗策略。
Pharmacol Ther. 2014 Jun;142(3):375-415. doi: 10.1016/j.pharmthera.2014.01.003. Epub 2014 Jan 22.
3
MicroRNA basis of physiological hypertrophy.生理性肥大的微小RNA基础。
Front Genet. 2013 Nov 26;4:253. doi: 10.3389/fgene.2013.00253. eCollection 2013.
4
MicroRNAs in the onset and development of cardiovascular disease.微小 RNA 在心血管疾病的发生和发展中的作用。
Clin Sci (Lond). 2014 Feb;126(3):183-94. doi: 10.1042/CS20130203.
5
microRNA in the development of diabetic complications.微小 RNA 在糖尿病并发症发展中的作用。
Clin Sci (Lond). 2014 Jan;126(2):95-110. doi: 10.1042/CS20130079.
6
Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts.糖尿病 Ins2+/-Akita 心脏中 Dicer、miRNAs 和炎症标志物的差异表达。
Cell Biochem Biophys. 2014 Jan;68(1):25-35. doi: 10.1007/s12013-013-9679-4.
7
Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.miRNAs 下调与氧化应激增加在糖尿病性心功能障碍发展中的关系：连接蛋白 junctin 作为 miR-1 的靶蛋白。
Cell Biochem Biophys. 2013;67(3):1397-408. doi: 10.1007/s12013-013-9672-y.
8
Predictors and prevention of diabetic cardiomyopathy.糖尿病性心肌病的预测与预防。
Diabetes Metab Syndr Obes. 2013 Apr 11;6:151-60. doi: 10.2147/DMSO.S30968. Print 2013.
9
miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart.miR-141 作为 1 型糖尿病心脏中线粒体磷酸盐载体（Slc25a3）的调节剂。
Am J Physiol Cell Physiol. 2012 Dec 15;303(12):C1244-51. doi: 10.1152/ajpcell.00137.2012. Epub 2012 Oct 3.
10
MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells.MicroRNA-204 对于人源性心肌祖细胞的分化是必需的。
J Mol Cell Cardiol. 2012 Dec;53(6):751-9. doi: 10.1016/j.yjmcc.2012.08.024. Epub 2012 Sep 7.
Zotero 插件